Misoprostol and ranitidine in the prevention of NSAID-induced ulcers: A prospective, double-blind, multicenter study

American Journal of Gastroenterology

Volumn 91, Issue 2, 1996, Pages 223-227

  Raskin, Jeffrey B ^a,f   White, Richard H ^b   Jaszewski, Richard ^c   Korsten, Mark A ^c   Schubert, Timothy T ^d   Fort, John G ^e  

^a UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c VETERANS AFFAIRS MEDICAL CENTER   (United States)

^d HENRY FORD HOSPITAL   (United States)

^e PFIZER INC   (United States)

^f UNIVERSITY OF MIAMI   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

IBUPROFEN; MISOPROSTOL; NAPROXEN; PIROXICAM; RANITIDINE; SULINDAC;

ABDOMINAL PAIN; ADULT; AGED; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIARRHEA; DOUBLE BLIND PROCEDURE; DRUG EFFECT; DRUG INDUCED DISEASE; DYSPEPSIA; FEMALE; FLATULENCE; GASTROINTESTINAL SYMPTOM; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; NAUSEA; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; STOMACH MUCOSA; ULCER;

ADMINISTRATION, ORAL; ADULT; AGED; AGED, 80 AND OVER; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ANTI-ULCER AGENTS; DOUBLE-BLIND METHOD; DUODENAL ULCER; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; MISOPROSTOL; RANITIDINE; RISK FACTORS; STOMACH ULCER; TIME FACTORS;

EID: 0030064350     PISSN: 00029270     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (24)

1. Miller TA. Protective effects of prostaglandins against gastric mucosal damage: Current knowledge and proposed mechanisms. Am J Physiol 1983;245:G601-23.
2. Cohen MM, Clark L, Armstrong, et al. Reduction of aspirin-induced fecal blood loss with low-dose misoprostol tablets in man. Dig Dis Sci 1985;30:605-11.
3. Leonards JR, Levy G, Niemczura R. Gastrointestinal blood loss during prolonged aspirin administration. N Engl J Med 1973;289:1020-22.
4. Magnusson B, Sölvell L, Arvidsson B. A comparative study of gastrointestinal bleeding during administration of ketoprofen and naproxen. Scand J Rheumatol 1977;6:62-4.
5. 2: An endoscopic study. Gastroenterology 1984;86:339-345.
6. Larkai EN, Smith JL, Lidsky MD, et al. Gastroduodenal mucosa and dyspeptic symptoms in arthritic patients during chronic nonsteroidal anti-inflammatory drug use. Am J Gastroenterol 1987;82:1153-8.
7. Graham DY, Agrawal NM, Roth SH. Prevention of NSAID-induced gastric ulcer with misoprostol: Multicentre, double-blind, placebo-controlled trial. Lancet 1988;8623:1277-80.
8. Graham DY, White RH, Moreland LW, et al. Duodenal and gastric ulcer prevention with misoprostol in arthritis patients taking NSAIDs. Ann Intern Med 1993;119:257-62.
9. Ehsanullah RSB, Page MC, Tildesley G, et al. Prevention of gastroduodenal damage induced by non-steroidal anti-inflammatory drugs: Controlled trial of ranitidine. Br Med J 1988;297:1017-21.
10. Robinson MG, Griffin JW, Bowers J, et al. Effect of ranitidine on gastroduodenal mucosal damage induced by nonsteroidal anti-inflammatory drugs. Dig Dis Sci 1989;34:424-8.
11. Caruso I, Porro GB. Gastroscopic evaluation of anti-inflammatory agents. Br Med J 1980;280:75-8.
12. Armstrong CP, Blower AL. Non-steroidal anti-inflammatory drugs and life-threatening complications of peptic ulceration. Gut 1987;28:527-32.
13. Graham DY, Smith JL. Gastroduodenal complications of chronic NSAID therapy. Am J Gastroenterol 1988;83:1081-4.
14. Rees WDW, Turnberg LA. Reappraisal of the effects of aspirin on the stomach. Lancet 1980;2:410-3.
15. Konturek SJ, Kwiecien N, Obtulowicz W, et al. Effect of carprofen and indomethacin on gastric function, mucosal integrity and generation of prostaglandins in men. Hepatogastroenterology 1982;29:267-70.
16. Shiokawa Y, Nobunaga M, Saito T, et al. Epidemiology study on GI lesions induced by non-steroidal anti-inflammatory drugs. Ryumachi 1991;31:96-111.
17. Bartle WR, Gupta AK, Lazor J. Nonsteroidal anti-inflammatory drugs and gastrointestinal bleeding. A case-control study. Arch Intern Med 1986;146:2365-7.
18. Lanza FL. A review of mucosal protection by synthetic prostaglandin E analogs against injury by non-steroidal anti-inflammatory agents. Scand J Gastroenterol 1989;24(suppl 163):36-43.
19. 1 analog misoprostol in man. Dig Dis Sci 1988;33:298-302.
20. Akdamar K, Agrawal N, Ertan A. Inhibition of nocturnal gastric secretion in normal human volunteers by misoprostol: A synthetic prostaglandin E, methyl ester analog. Am J Gastroenterol 1982;77: 902-4.
21. Silverstein FE, Graham DY, Senior JR, et al. Misoprostol reduces serious gastrointestinal complications in patients with rheumatoid arthritis receiving nonsteroidal antiinflammatory drugs. A randomized, double-blind, placebo controlled trial. Ann Intern Med 1995;123 (in press).
22. Loeb DS, Ahlquist DA, Tally NJ. Management of gastroduodenopathy with the use of nonsteroidal anti-inflammatory drugs. Mayo Clin Proc 1992;67:354-64.
23. Fries JF, Williams CA, Bloch DA, et al. Nonsteroidal anti-inflammatory drug-associated gastropathy: Incidence and risk factor models. Am J Med 1991;91:209-12.
24. Fries JF. Assessing and understanding risk. Scand J Rheumatol 1992; 92(suppl):21-4.